Drug Price Transparency
A federal judge yesterday struck down a Centers for Medicare & Medicaid Services final rule requiring drug companies to include list prices in direct-to-consumer television advertisements of products for which Medicare and Medicaid reimbursement is available.
The White House June 24 released an executive order on “improving price and quality transparency in American health care.” The executive order focuses on five policies:
The House Energy and Commerce Subcommittee on Health today held a hearing on seven bills aimed at improving transparency in the drug supply chain to lower prices.
The Centers for Medicare & Medicaid Services May 16 released a final rule with the intent of lowering drug prices for beneficiaries enrolled in Medicare Advantage and Part D programs.
The largest U.S. pharmaceutical and biotech companies spend just 22 cents out of every dollar on research and development, according to an analysis released today by the Campaign for Sustainable Rx Pricing.
A recent Health Affairs blog post (April 19) on hospital price transparency argues that chargemaster data can be confusing to consumers. We agree, and have encouraged the Department of Health and Human Services (HHS) to focus, instead, on the information that really matters to patients – expected…
The House Ways and Means Committee today approved the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act (H.R. 2113), AHA-supported legislation that would increase transparency with regard to prescription drug pricing.
AHA letter to Ways and Means Committee on the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act (H.R. 2113.
A recent report in MobiHealth News explores how well-funded, established startups and fledgling companies alike are finding ways to cut the costs of prescription medications. Their services are targeted to the more than 27 million consumers who are uninsured or underinsured — including the 43…
Civica Rx is the brainchild of hospitals and health systems that formed a collaborative to hold down the spiraling costs of essential generic drugs. How is the plan working out? Civica Rx President and CEO Martin VanTrieste shares an update on the organization’s efforts on a new AHA Advancing…